News
Symbiotec Pharmalab consolidated net profit declines 53.01% in the June 2026 quarter
23-Sep-2026 | 07:30
Sales rise 7.37% to Rs 218.15 crore
Net profit of Symbiotec Pharmalab declined 53.01% to Rs 14.06 crore in the quarter ended June 2026 as against Rs 29.92 crore during the previous quarter ended June 2025. Sales rose 7.37% to Rs 218.15 crore in the quarter ended June 2026 as against Rs 203.17 crore during the previous quarter ended June 2025.
| Particulars | Quarter Ended | ||
| Jun. 2026 | Jun. 2025 | % Var. | |
| Sales | 218.15 | 203.17 | 7 |
| OPM % | 20.72 | 28.53 | - |
| PBDT | 39.36 | 55.33 | -29 |
| PBT | 17.53 | 44.82 | -61 |
| NP | 14.06 | 29.92 | -53 |
Powered by Capital Market - Live News